Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus aureus | 3 | 2020 | 479 | 1.390 |
Why?
|
| Prosthesis-Related Infections | 2 | 2020 | 184 | 1.060 |
Why?
|
| Abscess | 2 | 2019 | 136 | 1.000 |
Why?
|
| Pneumonia, Viral | 2 | 2021 | 374 | 0.920 |
Why?
|
| Staphylococcal Infections | 2 | 2019 | 562 | 0.790 |
Why?
|
| Brucella Vaccine | 1 | 2021 | 1 | 0.710 |
Why?
|
| Brucella abortus | 1 | 2021 | 5 | 0.710 |
Why?
|
| Cronobacter sakazakii | 1 | 2021 | 4 | 0.710 |
Why?
|
| Brucellosis | 1 | 2021 | 19 | 0.700 |
Why?
|
| Central Nervous System Infections | 1 | 2021 | 21 | 0.700 |
Why?
|
| Dermatomycoses | 1 | 2021 | 17 | 0.700 |
Why?
|
| Cross Infection | 2 | 2022 | 332 | 0.690 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2021 | 57 | 0.680 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2019 | 230 | 0.680 |
Why?
|
| Mucormycosis | 1 | 2021 | 31 | 0.680 |
Why?
|
| Osteomyelitis | 2 | 2025 | 210 | 0.660 |
Why?
|
| Infant Formula | 1 | 2021 | 104 | 0.650 |
Why?
|
| Meningitis, Bacterial | 1 | 2021 | 98 | 0.650 |
Why?
|
| Adhesins, Bacterial | 1 | 2020 | 72 | 0.630 |
Why?
|
| Streptococcal Infections | 1 | 2022 | 251 | 0.620 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 266 | 0.620 |
Why?
|
| Anti-Bacterial Agents | 7 | 2022 | 2545 | 0.610 |
Why?
|
| Genes, Bacterial | 1 | 2020 | 216 | 0.610 |
Why?
|
| Texas | 7 | 2022 | 3614 | 0.610 |
Why?
|
| Biofilms | 1 | 2020 | 94 | 0.610 |
Why?
|
| Public Health | 1 | 2021 | 272 | 0.590 |
Why?
|
| Leukemia | 2 | 2021 | 373 | 0.580 |
Why?
|
| Head | 1 | 2019 | 111 | 0.570 |
Why?
|
| Trichosporonosis | 1 | 2018 | 8 | 0.570 |
Why?
|
| Orbital Cellulitis | 1 | 2018 | 15 | 0.560 |
Why?
|
| Neck | 1 | 2019 | 143 | 0.560 |
Why?
|
| Invasive Fungal Infections | 1 | 2018 | 21 | 0.560 |
Why?
|
| Opportunistic Infections | 1 | 2018 | 71 | 0.550 |
Why?
|
| Prostheses and Implants | 1 | 2019 | 147 | 0.540 |
Why?
|
| Coinfection | 1 | 2019 | 187 | 0.530 |
Why?
|
| Prostatic Diseases | 1 | 2017 | 13 | 0.520 |
Why?
|
| Infant | 11 | 2025 | 13277 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 284 | 0.510 |
Why?
|
| Angiostrongylus cantonensis | 1 | 2016 | 8 | 0.500 |
Why?
|
| Strongylida Infections | 1 | 2016 | 14 | 0.500 |
Why?
|
| Fever of Unknown Origin | 1 | 2016 | 43 | 0.490 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 312 | 0.480 |
Why?
|
| Brain | 5 | 2022 | 3189 | 0.470 |
Why?
|
| Hospitals, Pediatric | 4 | 2021 | 802 | 0.460 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 363 | 0.450 |
Why?
|
| Disease Management | 1 | 2019 | 559 | 0.440 |
Why?
|
| Child | 14 | 2025 | 26152 | 0.440 |
Why?
|
| Prostate | 1 | 2017 | 410 | 0.430 |
Why?
|
| Influenza, Human | 1 | 2019 | 700 | 0.390 |
Why?
|
| Child, Preschool | 9 | 2025 | 14976 | 0.390 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 849 | 0.340 |
Why?
|
| Adolescent | 7 | 2021 | 20724 | 0.310 |
Why?
|
| Disease Outbreaks | 2 | 2021 | 316 | 0.300 |
Why?
|
| Meningitis | 2 | 2022 | 98 | 0.300 |
Why?
|
| Retrospective Studies | 8 | 2025 | 17633 | 0.300 |
Why?
|
| Male | 14 | 2025 | 64493 | 0.290 |
Why?
|
| Humans | 22 | 2025 | 130357 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 3841 | 0.290 |
Why?
|
| Female | 14 | 2025 | 70272 | 0.280 |
Why?
|
| Neuroimaging | 3 | 2021 | 390 | 0.280 |
Why?
|
| Infant, Newborn | 4 | 2021 | 8525 | 0.270 |
Why?
|
| Treatment Outcome | 5 | 2021 | 12854 | 0.260 |
Why?
|
| Multiple Sclerosis | 2 | 2020 | 391 | 0.240 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2019 | 838 | 0.230 |
Why?
|
| Neisseriaceae Infections | 1 | 2025 | 3 | 0.230 |
Why?
|
| Kingella kingae | 1 | 2025 | 7 | 0.230 |
Why?
|
| Discitis | 1 | 2025 | 7 | 0.230 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2025 | 57 | 0.210 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2022 | 575 | 0.210 |
Why?
|
| Pandemics | 2 | 2021 | 1153 | 0.200 |
Why?
|
| DNA, Bacterial | 1 | 2025 | 488 | 0.200 |
Why?
|
| Streptococcus gallolyticus | 1 | 2022 | 3 | 0.190 |
Why?
|
| Encephalomalacia | 1 | 2022 | 4 | 0.190 |
Why?
|
| Paenibacillus | 1 | 2022 | 3 | 0.190 |
Why?
|
| Streptococcus | 1 | 2022 | 64 | 0.190 |
Why?
|
| Brain Abscess | 1 | 2022 | 54 | 0.180 |
Why?
|
| Hospitalization | 2 | 2021 | 1927 | 0.180 |
Why?
|
| Penicillins | 1 | 2022 | 153 | 0.180 |
Why?
|
| Rhizopus | 1 | 2021 | 10 | 0.180 |
Why?
|
| Herpesvirus 3, Human | 1 | 2021 | 29 | 0.170 |
Why?
|
| Rifampin | 1 | 2021 | 122 | 0.160 |
Why?
|
| Cattle | 1 | 2021 | 501 | 0.160 |
Why?
|
| Immunization | 1 | 2021 | 265 | 0.160 |
Why?
|
| Infection Control | 1 | 2021 | 160 | 0.160 |
Why?
|
| Hospitals | 1 | 2022 | 436 | 0.150 |
Why?
|
| Soft Tissue Infections | 1 | 2020 | 89 | 0.150 |
Why?
|
| Antibodies, Bacterial | 1 | 2021 | 412 | 0.150 |
Why?
|
| Voriconazole | 1 | 2018 | 28 | 0.140 |
Why?
|
| Lipopeptides | 1 | 2018 | 35 | 0.140 |
Why?
|
| Leukocidins | 1 | 2018 | 37 | 0.140 |
Why?
|
| Exotoxins | 1 | 2018 | 44 | 0.140 |
Why?
|
| Health Care Surveys | 1 | 2019 | 277 | 0.140 |
Why?
|
| Oxygen | 1 | 2022 | 551 | 0.140 |
Why?
|
| Echinocandins | 1 | 2018 | 42 | 0.140 |
Why?
|
| Amphotericin B | 1 | 2018 | 90 | 0.140 |
Why?
|
| Bacteremia | 1 | 2022 | 425 | 0.130 |
Why?
|
| Bacterial Toxins | 1 | 2018 | 170 | 0.130 |
Why?
|
| Shock, Septic | 1 | 2019 | 148 | 0.130 |
Why?
|
| Sepsis | 1 | 2022 | 494 | 0.130 |
Why?
|
| Skin | 1 | 2020 | 543 | 0.130 |
Why?
|
| Virulence Factors | 1 | 2018 | 180 | 0.130 |
Why?
|
| Neutropenia | 1 | 2018 | 203 | 0.130 |
Why?
|
| Emergency Medicine | 1 | 2019 | 175 | 0.130 |
Why?
|
| Proteus mirabilis | 1 | 2016 | 13 | 0.130 |
Why?
|
| Critical Illness | 1 | 2021 | 616 | 0.130 |
Why?
|
| White Matter | 1 | 2019 | 219 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2019 | 322 | 0.120 |
Why?
|
| Young Adult | 2 | 2021 | 9970 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 331 | 0.120 |
Why?
|
| Methylprednisolone | 1 | 2016 | 95 | 0.120 |
Why?
|
| Antifungal Agents | 1 | 2018 | 294 | 0.120 |
Why?
|
| Prednisone | 1 | 2016 | 238 | 0.120 |
Why?
|
| Eosinophilia | 1 | 2016 | 107 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1164 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2019 | 1221 | 0.110 |
Why?
|
| Age Factors | 1 | 2019 | 2834 | 0.100 |
Why?
|
| Length of Stay | 1 | 2018 | 1393 | 0.090 |
Why?
|
| Genotype | 1 | 2018 | 2606 | 0.090 |
Why?
|
| Electronic Health Records | 1 | 2019 | 811 | 0.090 |
Why?
|
| Pediatrics | 1 | 2019 | 1244 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2019 | 1212 | 0.070 |
Why?
|
| Animals | 2 | 2021 | 33909 | 0.070 |
Why?
|
| Hypercapnia | 1 | 2022 | 23 | 0.050 |
Why?
|
| Levofloxacin | 1 | 2022 | 49 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2022 | 298 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2022 | 114 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2022 | 273 | 0.040 |
Why?
|
| Hand | 1 | 2020 | 95 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2025 | 2111 | 0.040 |
Why?
|
| Diarrhea | 1 | 2022 | 311 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2025 | 1723 | 0.040 |
Why?
|
| Games, Recreational | 1 | 2019 | 11 | 0.040 |
Why?
|
| Knowledge | 1 | 2019 | 48 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2022 | 485 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 237 | 0.030 |
Why?
|
| Simulation Training | 1 | 2019 | 167 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 680 | 0.030 |
Why?
|
| Learning | 1 | 2019 | 371 | 0.030 |
Why?
|
| Pneumonia | 1 | 2019 | 338 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2019 | 327 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 5190 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2019 | 1046 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 28338 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 31093 | 0.010 |
Why?
|